Drug Topics

APRIL 7, 2023

Both acute and chronic infection can increase the risk of cognitive decline and dementia in older adults.

468

468

PhRMA

APRIL 7, 2023

PhRMA president and CEO Stephen J. Ubl spoke recently at The Hill’ s event, “ Pathways to Patient Affordability.” He spotlighted patients’ affordability challenges, the unintended consequences we’re already seeing from the government price setting provisions in the Inflation Reduction Act (IRA) and how policymakers can address harmful pharmacy benefit manager (PBM) practices.

Insurance 260

Insurance 260

Drug Topics

APRIL 7, 2023

Dupilumab monotherapy plus concomitant topical corticosteroids can improve signs, symptoms, and patient health-related quality of life.

407

407

Fierce Healthcare

APRIL 7, 2023

Layoffs are ramping up among hospitals and health systems.

Hospitals 143

Hospitals 143

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Drug Topics

APRIL 7, 2023

Continuous glucose monitors are poised to change diabetes management for patients.

247

247

Pharmacy Times

APRIL 7, 2023

Discussions are led by a variety of experienced preceptors to provide insight, strategies, and resources for pharmacy residents.

131

131

PharmaVoice

APRIL 7, 2023

The company’s chief operating and growth officer on her personal quirks and why every pharma leader should read "Getting Naked.

130

130

STAT

APRIL 7, 2023

I care deeply about privacy, and as a professional researcher, I take meticulous notes. During my recent maternity leave, I spent most of my hands-free time trying to figure out why my doctors were trying to give my medical data away to advertisers — even after I opted out.

129

129

Pharmacy Times

APRIL 7, 2023

Part 1 of this 2-part series examines USP and revisions for sterile and nonsterile compounding, veterinary compounding, FDA inspections of 503A pharmacies, and the interstate distribution of compounded prescriptions post Wellness Pharmacy v. FDA.

Compounding 123

Compounding FDA 123

STAT

APRIL 7, 2023

The road has run out for Pear Therapeutics: the pioneering digital therapeutics company filed for chapter 11 bankruptcy on Friday and will seek to sell off its assets to pay back its creditors. Pear will terminate 170 employees, or approximately 92% of its workforce, and will continue to operate in limited capacity with 15 employees as it seeks a buyer.

126

126

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharmacy Times

APRIL 7, 2023

Eye drops come in many forms and for many indications, such as redness, itchiness, dryness, allergies, dilating drops, glaucoma drops, lubricants, numbing agents, antibiotics, and to lower pressure.

123

123

STAT

APRIL 7, 2023

Liver disease researchers, stumped by a complex disease, are looking for new investigative tools. Artificial intelligence might be one of them.  At a small conference of the American Association for the Study of Liver Diseases in Los Angeles last month, experts gathered to compare notes on nonalcoholic steatohepatitis, a form of nonalcoholic fatty liver disease commonly known as NASH.

120

120

PharmExec

APRIL 7, 2023

Eli Lilly debuts its first Mounjaro TV commercial amid high demand for the diabetes injection, which also shows promise in weight loss applications and outperformed rivals Ozempic and Wegovy in clinical trials.

119

119

Fierce Healthcare

APRIL 7, 2023

Industry Voices—As healthcare's labor shortages worsen, masking remains critical pminemyer Fri, 04/07/2023 - 16:03

112

112

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

The Guardian - Pharmaceutical Industry

APRIL 7, 2023

Exclusive: Pharmaceutical firm says groundbreaking jabs could save millions of lives ‘A silver lining’: how Covid ushered in a vaccines golden era Millions of lives could be saved by a groundbreaking set of new vaccines for a range of conditions including cancer, experts have said. A leading pharmaceutical firm said it is confident that jabs for cancer, cardiovascular and autoimmune diseases, and other conditions will be ready by 2030.

Vaccines 111

Vaccines 111

Fierce Healthcare

APRIL 7, 2023

Sweeping new study analyzes maternal health outcomes with SDOH, finds Black mothers at much higher risk agliadkovskaya Fri, 04/07/2023 - 15:50

106

106

STAT

APRIL 7, 2023

When it comes to treating brain tumors, sometimes less is more in the operating room. If it’s a lymphoma, a doctor might want to just get enough tissue to confirm the diagnosis and get out. If it’s an astrocytoma, a surgeon will want to cut out every possible piece of the tumor. The same goes for oligodendroglioma, though for these tumors, getting out the last of a tumor may not be worth damaging the patient’s ability to walk or speak.

104

104

Fierce Healthcare

APRIL 7, 2023

Digital pathology experts say that human-centered augmented intelligence will remain the standard for pathology, radiology aburky Fri, 04/07/2023 - 16:13

106

106

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

STAT

APRIL 7, 2023

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others.   That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week.

98

98

Drug Store News

APRIL 7, 2023

A retrospective study showed high patient satisfaction and cost savings from the fertility order review program.

98

98

Fierce Healthcare

APRIL 7, 2023

RAND: Audio-only telehealth still popular among safety-net providers rking Fri, 04/07/2023 - 17:03

98

98

Drug Store News

APRIL 7, 2023

The collection features an intensive repair solution that rebuilds broken bonds inside the hair while replenishing the outside barrier, the company said.

98

98

European Pharmaceutical Review

APRIL 7, 2023

A new, sustained-release chemotherapy delivery device inserted into the bladder, facilitated tumour response, a study has reported. The treatment was given to elderly patients with advanced bladder cancer who were medically unfit for standard treatment. The intravesical device, TAR-200, provides continuous, low-dose, local delivery of gemcitabine chemotherapy. “TAR-200 was generally safe, well tolerated, and had beneficial effects on bladder cancer outcomes,” commented lead author Dr

Chemotherapy 98

Chemotherapy Mayo Clinic 98

Drug Store News

APRIL 7, 2023

Walmart plans to install new fast-charging stations at thousands of Walmart and Sam’s Club locations across the country.

98

98

PharmExec

APRIL 7, 2023

It’s time for pharma brands to recognize the potential of TikTok as a promotional platform and develop a strategy to not only stand out but make an impact.

98

98

Drug Store News

APRIL 7, 2023

The Kindness+ line includes two plant-based hand cleansers and moisturizers infused with hyaluronic acid and vitamin C.

98

98

STAT

APRIL 7, 2023

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is, once gain, rather modest. We plan to promenade with the official mascot and his stay-over playmate, catch up on our reading, and hold another listening party with Mrs. Pharmalot — the rotation will include this , this and this.

FDA 97

FDA 97

Drug Store News

APRIL 7, 2023

DSN interviewed Omar Abdelsamad, executive director of patient recruitment, clinical trial services at CVS Health, about the company’s entry into a new therapeutic space—chronic kidney disease.

98

98

Pharmaceutical Technology

APRIL 7, 2023

The US Food and Drug Administration (FDA) has rescinded its approval for Swiss drug maker Covis Pharma’s (Covis) Makena drug and its generic versions , the only approved treatments aimed at reducing the risk of premature birth. The decision was made after studies did not prove the effectiveness of the drug in preventing preterm birth. Makena was approved by the FDA under the accelerated approval pathway in 2011 to reduce the risk of preterm birth in women with a singleton pregnancy who hav

FDA 97

FDA 97

Drug Store News

APRIL 7, 2023

In line with perceptions that consumers are less prone to buying bigger-ticket items in today’s economy, Costco’s March sales report showed resilience in food and downturns in nonfoods.

98

98

Pharmaceutical Technology

APRIL 7, 2023

The US Food and Drug Administration (FDA) has rescinded its approval for Swiss drug maker Covis Pharma’s (Covis) Makena drug and its generic versions , the only approved treatments aimed at reducing the risk of premature birth. The decision was made after studies did not prove the effectiveness of the drug in preventing preterm birth. Makena was approved by the FDA under the accelerated approval pathway in 2011 to reduce the risk of preterm birth in women with a singleton pregnancy who hav

FDA 95

FDA 95

Drug Store News

APRIL 7, 2023

The new line of treats features crunchy brownie brittle crisps infused with M&M’s Minis.

96

96

The Checkup by Singlecare

APRIL 7, 2023

Over-the-counter medications may provide an illusion of safety since they are available without a prescription. However, taking more than one OTC treatment at a time can have very serious consequences. Benadryl (diphenhydramine) and Zyrtec (cetririzine) are the brand names of common oral antihistamines. Here is what providers say about mixing these two over-the-counter allergy medications.

Compounding 94

Compounding FDA 94